NCT05155852

Brief Summary

The purpose of this research study is to develop a protocol for NIRS-based bedside monitoring to identify impaired cerebral autoregulation in women admitted to the high-risk obstetrics unit with postpartum hypertension. The investigators will then pilot this protocol in 10 patients with high-risk neurological features, such as headache.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 13, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 14, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2023

Completed
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

1.6 years

First QC Date

December 1, 2021

Last Update Submit

September 19, 2024

Conditions

Keywords

Near-infrared spectroscopy (NIRS)PreeclampsiaPregnancy

Outcome Measures

Primary Outcomes (3)

  • Oxygenated hemoglobin concentration

    The Edwards HemoSphere system with ForeSight Elite NIRS component (Edwards LifeSciences) will be used to monitor oxygenated and deoxygenated hemoglobin concentrations. Two adhesive NIRS probes will be placed on the frontotemporal scalp covering the cortex, usually supplied by the middle cerebral artery. \[Describe how the concentration will be obtained, the range of anticipated concentrations, and how to interpret the concentrations - eg, higher concentrations indicate ...\]

    Continuously collected for up to 24 hours

  • Deoxygenated hemoglobin concentration

    The Edwards HemoSphere system with ForeSight Elite NIRS component (Edwards LifeSciences) will be used to monitor oxygenated and deoxygenated hemoglobin concentrations. Two adhesive NIRS probes will be placed on the frontotemporal scalp covering the cortex, usually supplied by the middle cerebral artery.

    Continuously collected for up to 24 hours

  • Blood pressure (BP)

    Continuous non-invasive BP monitoring will be utilized (ClearSight finger cuff system, Edwards LifeSciences).

    Continuously collected for up to 24 hours

Study Arms (1)

Post-delivery preeclampsia patients

Women admitted to the high-risk unit(s) with elevated blood pressure and neurological symptoms, such as headache, after delivery.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be recruited from the high-risk inpatient obstetrics unit at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. Women who have given birth within the previous 12 weeks and are admitted to the high-risk inpatient obstetrics unit for management of hypertension will be screened.

You may qualify if:

  • Women who have given birth within the previous 12 weeks
  • Admitted to the high-risk inpatient obstetrics unit for management of hypertension
  • With headache or other neurological symptoms such as vision changes

You may not qualify if:

  • Acute ischemic stroke
  • Intracerebral or subarachnoid hemorrhage
  • Eclamptic seizures
  • Any other neurological complication requiring transfer to the neurological intensive care unit or stroke stepdown unit
  • History of Reynaud's syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center / NewYork-Presbyterian Hospital (NYP)

New York, New York, 10032, United States

Location

Related Publications (1)

  • Petersen NH, Silverman A, Strander SM, Kodali S, Wang A, Sansing LH, Schindler JL, Falcone GJ, Gilmore EJ, Jasne AS, Cord B, Hebert RM, Johnson M, Matouk CC, Sheth KN. Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke. Stroke. 2020 Mar;51(3):914-921. doi: 10.1161/STROKEAHA.119.026596. Epub 2020 Feb 12.

    PMID: 32078493BACKGROUND

MeSH Terms

Conditions

Pre-EclampsiaHypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Eliza Miller, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Neurology in the Division of Stroke and Cerebrovascular Disease

Study Record Dates

First Submitted

December 1, 2021

First Posted

December 14, 2021

Study Start

August 13, 2021

Primary Completion

March 13, 2023

Study Completion

March 13, 2023

Last Updated

September 23, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations